Rise Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-121
Closed -$51.8K – 671
2025
Q3
$51.8K Buy
121
+7
+6% +$2.71K 0.02% 245
2025
Q2
$43.8K Hold
114
– – 0.02% 268
2025
Q1
$39.4K Buy
114
+2
+2% +$643 0.02% 273
2024
Q4
$33.6K Buy
112
+2
+2% +$699 0.02% 346
2024
Q3
$44.5K Buy
110
+1
+0.9% +$366 0.02% 262
2024
Q2
$35.2K Hold
109
– – 0.02% 315
2024
Q1
$36.4K Buy
+109
New +$33.3K 0.02% 309

Other funds holding HCA

Rise Advisors's HCA Position: Q4 2025 in Review

Rise Advisors sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 121 shares — an estimated $51.8K sold.

Rise Advisors first reported a position in HCA in Q1 2024 and held it in 7 quarters. The position peaked at $51.8K in Q3 2025. 1,399 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

  • Rise Advisors reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 121 HCA Healthcare shares in Q4 2025, an estimated $51.8K.
  • Rise Advisors first reported a position in HCA Healthcare in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's HCA Healthcare position peaked at $51.8K in Q3 2025.
  • 1,399 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.